Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

150 companies

Ticker	Company	Revenue	Net income ▾	Net margin	Return on equity	Revenue growth	Diluted EPS
GILD	Gilead Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$29.44B	$8.51B	28.9%	37.6%	2.4%	$6.78
AMGN	Amgen Inc Manufacturing · Year ended 2025-12-31 · USD	$36.75B	$7.71B	21.0%	89.1%	10.0%	$14.23
BIIB	Biogen Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.89B	$1.29B	13.1%	7.1%	2.2%	$8.79
EXEL	Exelixis, Inc. Manufacturing · Year ended 2026-01-02 · USD	$2.32B	$782.57M	33.7%	36.2%	7.0%	$2.78
NBIX	Neurocrine Biosciences Inc Manufacturing · Year ended 2025-12-31 · USD	$2.86B	$478.60M	16.7%	14.7%	21.4%	$4.67
NVAX	Novavax Inc Manufacturing · Year ended 2025-12-31 · USD	$1.12B	$440.30M	39.2%	n/a	64.7%	$2.58
QGEN	Qiagen N.V. Manufacturing · Year ended 2025-12-31 · USD	$2.09B	$424.88M	20.3%	11.2%	5.7%	$1.94
HALO	Halozyme Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.40B	$316.89M	22.7%	649.2%	37.6%	$2.56
BCRX	BioCryst Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$874.84M	$263.86M	30.2%	n/a	94.1%	$1.21
KRYS	Krystal Biotech, Inc. Manufacturing · Year ended 2025-12-31 · USD	$389.13M	$204.83M	52.6%	16.8%	33.9%	$6.84
TECH	Bio-Techne Corp Manufacturing · Year ended 2026-06-30 · USD	$1.22B	$181.86M	15.0%	8.6%	-0.4%	$1.16
CHRS	Coherus Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$168.02M	n/a	275.4%	n/a	$1.43
ADMA	ADMA Biologics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$510.17M	$146.93M	28.8%	30.8%	19.6%	$0.60
ELUT	Elutia Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$53.38M	n/a	192.9%	n/a	$0.87
RGEN	Repligen Corp Manufacturing · Year ended 2025-12-31 · USD	$738.26M	$48.89M	6.6%	2.3%	16.4%	$0.86
CGEN	Compugen Ltd Manufacturing · Year ended 2025-12-31 · USD	$72.76M	$35.34M	48.6%	34.4%	161.1%	$0.38
ATRA	Atara Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$120.77M	$32.69M	27.1%	n/a	-6.3%	$2.57
BDTX	Black Diamond Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$70.00M	$22.37M	32.0%	19.9%	n/a	$0.39
VCEL	Vericel Corp Manufacturing · Year ended 2025-12-31 · USD	$276.26M	$16.52M	6.0%	4.7%	16.5%	$0.32
VXRT	Vaxart, Inc. Manufacturing · Year ended 2025-12-31 · USD	$237.26M	$16.33M	6.9%	18.6%	726.7%	$0.07
SABS	SAB Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$13.27M	n/a	8.8%	n/a	-$0.79
BKHA	Black Hawk Acquisition Corp Manufacturing · Year ended 2025-11-30 · USD	n/a	$1.33M	n/a	n/a	n/a	n/a
GPLB	Green Planet Bio Engineering Co. Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$35.8K	n/a	n/a	n/a	$0.00
AGTX	Agentix Corp. Manufacturing · Year ended 2026-03-31 · USD	n/a	-$485.6K	n/a	n/a	n/a	-$0.01
CPMV	Mosaic ImmunoEngineering Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$687.8K	n/a	n/a	n/a	-$0.10
CSBR	Champions Oncology, Inc. Manufacturing · Year ended 2026-04-30 · USD	$59.42M	-$1.18M	-2.0%	-29.8%	4.4%	-$0.08
ABPO	Abpro Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$2.89M	n/a	n/a	n/a	-$1.30
AGEN	Agenus Inc Manufacturing · Year ended 2025-12-31 · USD	$114.20M	-$3.08M	-2.7%	n/a	10.4%	$0.00
VISK	Viskase Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$3.41M	n/a	n/a	n/a	-$0.07
APTN	Adaptin Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$5.17M	n/a	n/a	n/a	-$0.66
ZEOX	Zeo ScientifiX, Inc. Manufacturing · Year ended 2025-10-31 · USD	$5.20M	-$5.52M	-106.2%	n/a	12.5%	-$0.86
ELOX	Eloxx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$6.00M	n/a	n/a	-100.0%	-$0.49
CELZ	Creative Medical Technology Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.0K	-$6.00M	n/m	-79.8%	-45.5%	-$2.52
PLX	Protalix BioTherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$52.74M	-$6.60M	-12.5%	-13.7%	-1.2%	-$0.08
DYAI	Dyadic International Inc Manufacturing · Year ended 2025-12-31 · USD	$3.09M	-$7.36M	-238.3%	-597.6%	-11.6%	-$0.23
CRIS	Curis Inc Manufacturing · Year ended 2025-12-31 · USD	$9.44M	-$7.58M	-80.3%	-138.8%	-13.4%	-$0.58
BCDA	BioCardia, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$8.23M	n/a	-919.3%	-100.0%	n/a
SCNI	Scinai Immunotherapeutics Ltd. Manufacturing · Year ended 2025-12-31 · USD	$1.31M	-$8.31M	-633.6%	-102.5%	99.2%	n/a
EXOZ	Exozymes Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$9.16M	n/a	-269.6%	n/a	-$1.09
IPSC	Century Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$109.16M	-$9.58M	-8.8%	-6.0%	n/m	-$0.14
FENC	Fennec Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$44.64M	-$9.74M	-21.8%	-27.5%	-6.1%	-$0.34
LIMN	Liminatus Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.21M	n/a	n/a	n/a	-$0.43
BCLI	Brainstorm Cell Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.31M	n/a	n/a	n/a	-$1.11
GRML	Greenland Mines Ltd Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.55M	n/a	-111.5%	n/a	-$0.22
ENTX	Entera Bio Ltd. Manufacturing · Year ended 2025-12-31 · USD	$42.0K	-$11.44M	n/m	-87.3%	-76.8%	$0.25
INTS	Intensity Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.61M	n/a	-97.7%	n/a	-$8.56
SLXN	Silexion Therapeutics Corp Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.91M	n/a	-457.6%	n/a	$8.96
INKT	MiNK Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$12.49M	n/a	n/a	n/a	-$2.93
ESLA	Estrella Immunopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$13.06M	n/a	n/a	n/a	-$0.35
VIVS	VivoSim Labs, Inc. Manufacturing · Year ended 2026-03-31 · USD	$131.0K	-$13.84M	n/m	n/a	-9.0%	-$5.35
AIM	AIM ImmunoTech Inc. Manufacturing · Year ended 2025-12-31 · USD	$88.0K	-$13.96M	n/m	n/a	-48.2%	-$8.62
PALI	Palisade Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$16.78M	n/a	-13.0%	n/a	-$0.30
PMCB	PharmaCyte Biotech, Inc. Manufacturing · Year ended 2026-04-30 · USD	$0	-$19.42M	n/a	-58.3%	n/a	-$2.77
INAB	IN8BIO, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$19.44M	n/a	-70.5%	n/a	-$4.44
CLDI	Calidi Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$19.91M	n/a	-529.6%	n/a	-$5.95
CERO	Cero Therapeutics Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$19.92M	n/a	n/a	n/a	n/a
ACOG	Alpha Cognition Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.22M	-$20.67M	-202.2%	-33.1%	n/a	-$1.18
CGTX	Cognition Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$23.49M	n/a	-68.5%	n/a	-$0.32
PLUR	Pluri Inc. Manufacturing · Year ended 2026-06-30 · USD	$1.02M	-$23.82M	n/m	n/a	-24.0%	-$2.44
ALGS	Aligos Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.19M	-$24.19M	n/m	-45.2%	-39.5%	-$2.45
CVM	CEL SCI Corp Manufacturing · Year ended 2025-09-30 · USD	n/a	-$25.41M	n/a	-159.2%	n/a	-$6.27
TVGN	Tevogen Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.28M	n/a	n/a	n/a	-$8.08
IMCR	Immunocore Holdings plc Manufacturing · Year ended 2025-12-31 · USD	$400.02M	-$35.51M	-8.9%	-9.3%	29.0%	-$0.71
CADL	Candel Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$38.18M	n/a	-73.5%	n/a	-$0.72
GLUE	Monte Rosa Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$123.67M	-$38.63M	-31.2%	-16.6%	63.5%	n/a
HUMA	Humacyte, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.04M	-$40.83M	n/m	n/m	n/a	-$0.26
PTHS	Pelthos Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$16.80M	-$43.32M	-257.9%	-111.4%	n/a	-$23.04
KLRS	Kalaris Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$43.44M	n/a	-55.1%	n/a	-$2.85
IMA	ImageneBio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$800.0K	-$45.35M	n/m	-34.1%	-77.1%	-$9.64
PASG	Passage BIO, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$45.52M	n/a	-242.7%	n/a	-$14.35
DTIL	Precision Biosciences Inc Manufacturing · Year ended 2025-12-31 · USD	$34.26M	-$45.72M	-133.4%	-49.6%	-50.1%	-$3.56
CRDF	Cardiff Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$593.0K	-$45.85M	n/m	-101.0%	-13.2%	-$0.69
INMB	Inmune Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$50.0K	-$45.93M	n/m	-195.3%	257.1%	-$1.86
AVXL	Anavex Life Sciences Corp. Manufacturing · Year ended 2025-09-30 · USD	n/a	-$46.38M	n/a	-48.9%	n/a	-$0.54
IKT	Inhibikase Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$48.26M	n/a	-27.9%	n/a	-$0.49
IVVD	Invivyd, Inc. Manufacturing · Year ended 2025-12-31 · USD	$53.43M	-$52.49M	-98.2%	-21.7%	110.5%	-$0.30
TARA	Protara Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$57.44M	n/a	-29.2%	n/a	-$1.34
ADPT	Adaptive Biotechnologies Corp Manufacturing · Year ended 2025-12-31 · USD	$276.98M	-$59.50M	-21.5%	-27.2%	54.8%	-$0.39
BCAB	BioAtla, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.61M	n/a	-164.7%	n/a	-$1.01
SNTI	Senti Biosciences Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$22.0K	-$61.44M	n/m	n/m	n/a	-$2.73
OTLK	Outlook Therapeutics, Inc. Manufacturing · Year ended 2025-09-30 · USD	$1.41M	-$62.42M	n/m	n/a	n/a	-$1.79
LCTX	Lineage Cell Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$14.56M	-$63.53M	-436.5%	-146.6%	53.2%	-$0.28
TARS	Tarsus Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$451.36M	-$66.42M	-14.7%	-19.3%	146.7%	-$1.59
CMPX	Compass Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$66.49M	n/a	-33.8%	-100.0%	n/a
OCGN	Ocugen, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.41M	-$67.85M	n/m	n/a	8.8%	n/a
ZURA	Zura Bio Ltd Manufacturing · Year ended 2025-12-31 · USD	n/a	-$68.65M	n/a	-67.6%	n/a	-$1.06
TIL	Instil Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$71.37M	n/a	-62.7%	n/a	-$10.70
ATYR	aTYR PHARMA INC Manufacturing · Year ended 2025-12-31 · USD	$190.0K	-$74.12M	n/m	-109.8%	-19.1%	-$0.80
TECX	Tectonic Therapeutic, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$74.15M	n/a	-29.5%	n/a	-$4.05
JSPR	Jasper Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$75.80M	n/a	n/m	n/a	-$3.95
TWST	Twist Bioscience Corp Manufacturing · Year ended 2025-09-30 · USD	$376.57M	-$77.67M	-20.6%	-16.4%	20.3%	-$1.30
XFOR	X4 Pharmaceuticals, Inc Manufacturing · Year ended 2025-12-31 · USD	$35.11M	-$79.20M	-225.6%	-42.5%	n/m	-$1.87
BEAM	Beam Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$139.74M	-$79.99M	-57.2%	-6.5%	120.0%	-$0.81
LENZ	LENZ Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$19.09M	-$82.13M	-430.3%	-28.9%	n/a	-$2.85
ARTV	Artiva Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$83.86M	n/a	-76.3%	-100.0%	-$3.43
QNCX	Quince Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$83.98M	n/a	n/a	n/a	-$1.68
MGX	Metagenomi Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$25.21M	-$87.87M	-348.5%	-55.4%	-51.8%	-$2.36
TNYA	Tenaya Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$90.60M	n/a	-73.5%	n/a	-$0.59
LXEO	Lexeo Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$99.96M	n/a	-40.5%	n/a	-$1.86
CCCC	C4 Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$35.95M	-$104.99M	-292.1%	-40.9%	1.0%	-$1.27

Rows per page: 25 50100